Disease | metabolic syndrome x |
Symptom | C0042373|vascular disease |
Sentences | 67 |
PubMedID- 23524050 | The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease. |
PubMedID- 21318102 | Increasing plasma apn or enhancing apn signal transduction may be an ideal strategy to prevent and treat the cardiovascular diseases associated with metabolic syndrome. |
PubMedID- 24819036 | Changes in concentration and several single-nucleotide polymorphisms (snp) at the gpx3 gene have been associated with vascular diseases, but the relationship of gpx3 with metabolic syndrome (mets) remains unexplored. |
PubMedID- 23334870 | This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting. |
PubMedID- 25857370 | Background and purpose: increased level of very low-density lipoprotein (vldl) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases. |
PubMedID- 20671994 | On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome. |
PubMedID- 24553695 | Dietary echium oil increases long-chain n-3 pufas, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome. |
PubMedID- 25916279 | Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome. |
PubMedID- 21516134 | Although several studies have reported that the chemerin/chemr23 axis is strongly associated with cardiovascular disease and aspects of metabolic syndrome11, 26, 27, there was no direct evidence for the role of the chemerin/chemr23 axis in maintaining endothelial function. |
PubMedID- 19720470 | Insulin resistance (ir), which is a major component of metabolic syndrome (mets), is associated with cardiovascular disease risk. |
PubMedID- 24393433 | Objective: metabolic syndrome (mets) is associated with cardiovascular disease (cvd). |
PubMedID- 23961478 | For high-risk patients, ldl-c treatment goal was ldl <100 mg/dl but an ldl-c goal of <70 mg/dl was considered a therapeutic option for very high risk patients who had recent heart attacks, cardiovascular disease with diabetes, metabolic syndrome, or severe/poorly controlled risk factors. |
PubMedID- 19958158 | Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress. |
PubMedID- 20004035 | Aims: to compare the cardiovascular disease (cvd) risk associated with the metabolic syndrome (mets) and dysglycemia, independent of each other during a median follow-up of 6.7 years. |
PubMedID- 20488778 | In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome. |
PubMedID- 23257741 | Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches. |
PubMedID- 23323622 | Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. |
PubMedID- 22417140 | Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease. |
PubMedID- 24498934 | Furthermore, in concordance with studies performed in healthy individuals , we observed a strong relation between ev-cystatin c and the metabolic syndrome in patients with clinically manifest vascular disease. |
PubMedID- 21654497 | In the univariate analysis, variables significantly associated with hypertension were age, waist circumference, established cardiovascular disease, family history of hypertension, lipoatrophy, metabolic syndrome, duration of infection, cd4 nadir, hiv rna <50 copies/ml, and antiretroviral treatment. |
PubMedID- 22877354 | Data from a community based study was used to assess the risk for type 2 diabetes, cardiovascular disease and prevalence of metabolic syndrome in middle-aged men. |
PubMedID- 21766575 | The association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study. |
PubMedID- 21841320 | Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd). |
PubMedID- 22417460 | High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. |
PubMedID- 23873328 | Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure. |
PubMedID- 25957218 | Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease. |
PubMedID- 23677576 | Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome. |
PubMedID- 22205060 | The emphasis on diagnosing and treating the individual risk factors should help in the prevention of the cardiovascular disease associated with obesity, the metabolic syndrome and type 2 diabetes. |
PubMedID- 21845221 | Nafld is becoming a risk factor for diabetes and cardiovascular diseases (cvds) independently of insulin resistance, metabolic syndrome, plasma lipid levels, and other usual risk factors . |
PubMedID- 21123363 | The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow delivery/distribution and local metabolism. |
PubMedID- 23199128 | In this review, we first describe the population trend in the degree of obesity as measured by the body mass index (bmi), and review prospective cohort studies that reported associations of obesity measures and metabolic syndrome (mets) with cardiovascular diseases (cvd) in japanese. |
PubMedID- 21808142 | Cd36 deficiency is related to phenotypic expression of the metabolic syndrome, frequently associated with atherosclerotic cardiovascular diseases resulting in raised levels of glucose thereby contributing to type 2 diabetes (t2dm). |
PubMedID- 25633268 | Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd). |
PubMedID- 26089614 | Abdominal obesity (ao) and metabolic syndrome (mets) are associated with the cardiovascular disease and type 2 diabetes. |
PubMedID- 20940070 | Analysis results on population attributable risks showed that about a quarter of total diabetes occurrence and more than 10% of cardiovascular disease was attributable to the metabolic syndrome. |
PubMedID- 25248654 | Studies linking low testosterone to the metabolic syndrome (with its sequelae cardiovascular disease and diabetes mellitus) and inflammation have been predominantly performed in elderly men. |
PubMedID- 23306779 | Moreover, vascular insulin resistance negatively impacts vascular health by affecting blood pressure regulation, vessel wall inflammation and atherogenesis thereby contributing to the burden of vascular disease seen with diabetes and metabolic syndrome. |
PubMedID- 24396692 | Furthermore, nafld is emerging as a risk factor for diabetes and cardiovascular disease, independently of insulin resistance, metabolic syndrome, plasma lipid level, and other traditional risk factors 2. |
PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity . |
PubMedID- 22359422 | The metabolic syndrome among patients with cardiovascular disease in accra, ghana. |
PubMedID- 21466628 | Based on the increased cardiovascular disease risk of the metabolic syndrome, which is similar to stage 1 hypertension, both lifestyle modification and arb therapy are justifiable. |
PubMedID- 20553596 | Given the prognostic significance of the metabolic syndrome in patients with vascular disease, we evaluated the association of vfa, sfa and lfp with metabolic syndrome in a high-risk vascular cohort. |
PubMedID- 24716162 | It is also strongly related to other pathological conditions, including obesity, diabetes, cardiovascular diseases, and symptoms of metabolic syndrome. |
PubMedID- 20823276 | Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome. |
PubMedID- 21679922 | Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome. |
PubMedID- 22682107 | Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit. |
PubMedID- 20508159 | The hypothesis that rimonabant has protective effects against vascular disease associated with the metabolic syndrome was tested using jcr:la-cp rats. |
PubMedID- 20689417 | Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease. |
PubMedID- 20349347 | The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities. |
PubMedID- 21130454 | Given the frequent concordance of metabolic diseases including diabetes, obesity, and metabolic syndrome with cardiovascular diseases associated with hyperlipidemia, it is important to understand the potential metabolic risks and benefits of therapies with distinct statins. |
Page: 1 2